{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T11:46:23Z","timestamp":1782560783774,"version":"3.54.5"},"reference-count":15,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T00:00:00Z","timestamp":1782000000000},"content-version":"vor","delay-in-days":20,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Altered mental status (AMS) in oncology populations frequently reflects complex interactions among medical, pharmacologic, and neuropsychiatric factors. Accurate identification of the primary contributors is crucial to minimize morbidity. We report the case of a man in his 60s with a relapsed plasma cell malignancy, status post autologous stem-cell transplant, who experienced recurrent AMS during ongoing combination chemotherapy and psychiatric polypharmacy. Neuroimaging excluded structural or vascular lesions. Laboratory evaluation revealed intermittent mild renal dysfunction without metabolic crisis. His medication regimen included multiple serotonergic, dopaminergic, and sedative agents; clinical improvement followed medication rationalization. This case highlights the multifactorial nature of AMS in cancer survivors, in which post-transplant neuroinflammation, systemic metabolic stress, and overlapping drug effects create a brain vulnerable to toxic-metabolic encephalopathy. A systems-based, interdisciplinary approach is essential for diagnosing and preventing AMS in post-transplant oncology patients. Early recognition and medication simplification can reduce recurrence and enhance cognitive function.<\/jats:p>","DOI":"10.1093\/omcr\/omag107","type":"journal-article","created":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T11:46:31Z","timestamp":1778931991000},"source":"Crossref","is-referenced-by-count":0,"title":["Neuropsychiatric-pharmacologic synergy: interaction between psychiatric polypharmacy and cancer treatment-related neurotoxicity"],"prefix":"10.1093","volume":"2026","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-5426-2423","authenticated-orcid":false,"given":"Sean P","family":"Woytowitz","sequence":"first","affiliation":[{"name":"Department of Psychiatry and the Behavioral Sciences, Keck School of Medicine of USC , 1975 Zonal Ave, Los Angeles, CA 90033 ,","place":["United States of America"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Manchee","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and the Behavioral Sciences, Keck Medicine of USC , 1500 San Pablo St, Los Angeles, CA 90033 ,","place":["United States of America"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,6,21]]},"reference":[{"key":"2026062707165968000_ref1","doi-asserted-by":"publisher","first-page":"e2021","DOI":"10.1002\/onco.13867","article-title":"Neurocognitive impairment after hematopoietic stem cell transplant for hematologic malignancies: phenotype and mechanisms","volume":"26","author":"Harrison","year":"2021","journal-title":"Oncologist"},{"key":"2026062707165968000_ref2","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1093\/annonc\/mdz410","article-title":"Cancer-related cognitive impairment: an update on state of the art, detection, and management strategies in cancer survivors","volume":"30","author":"Lange","year":"2019","journal-title":"Ann Oncol"},{"key":"2026062707165968000_ref3","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1177\/87551225211073942","article-title":"Potential drug interactions between psychotropics and intravenous chemotherapeutics used by patients with cancer","volume":"38","author":"Turossi-Amorim","year":"2022","journal-title":"J Pharm Technol"},{"key":"2026062707165968000_ref4","doi-asserted-by":"publisher","first-page":"e70253","DOI":"10.1002\/pcn5.70253","article-title":"Incidence and associated factors of delirium after hematopoietic stem cell transplantation: a retrospective study","volume":"4","author":"Otsuki","year":"2025","journal-title":"PCN Rep"},{"key":"2026062707165968000_ref5","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/acps.13505","article-title":"Delirium-associated medication in people at risk: a systematic update review, meta-analyses, and GRADE-profiles","volume":"147","author":"Reisinger","year":"2022","journal-title":"Acta Psychiatr Scand"},{"key":"2026062707165968000_ref6","doi-asserted-by":"publisher","first-page":"e2813802","DOI":"10.1001\/jamanetworkopen.2023.50963","article-title":"Cumulative update of a systematic overview evaluating interventions addressing polypharmacy in adults","volume":"7","author":"Keller","year":"2024","journal-title":"JAMA Netw Open"},{"key":"2026062707165968000_ref7","doi-asserted-by":"publisher","first-page":"334.e1","DOI":"10.1016\/j.jtct.2023.01.028","article-title":"Delirium and healthcare utilization in patients undergoing hematopoietic stem cell transplantation","volume":"29","author":"Amonoo","year":"2023","journal-title":"Transplant Cell Ther"},{"key":"2026062707165968000_ref8","doi-asserted-by":"publisher","first-page":"294","DOI":"10.3390\/toxics3030294","article-title":"An overview of Bortezomib-induced neurotoxicity","volume":"3","author":"Meregalli","year":"2015","journal-title":"Toxics."},{"key":"2026062707165968000_ref9","doi-asserted-by":"publisher","first-page":"2366","DOI":"10.1182\/blood-2015-07-567958","article-title":"The novel mechanism of lenalidomide activity","volume":"126","author":"Fink","year":"2015","journal-title":"Blood."},{"key":"2026062707165968000_ref10","doi-asserted-by":"publisher","first-page":"S130","DOI":"10.1016\/j.bbmt.2017.12.073","article-title":"Gastrointestinal toxicity of high-dose melphalan in autologous stem-cell transplantation: identification of risk factors and a benchmark for experimental therapies","volume":"24","author":"Gordillo","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"2026062707165968000_ref11","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1146\/annurev-clinpsy-050817-084903","article-title":"Cognitive effects of cancer and cancer treatments","volume":"14","author":"Ahles","year":"2018","journal-title":"Annu Rev Clin Psychol"},{"key":"2026062707165968000_ref12","doi-asserted-by":"publisher","first-page":"1178646919873925","DOI":"10.1177\/1178646919873925","article-title":"Serotonin syndrome: pathophysiology, clinical features, management, and potential future directions","volume":"12","author":"Scotton","year":"2019","journal-title":"Int J Tryptophan Res"},{"key":"2026062707165968000_ref13","doi-asserted-by":"publisher","first-page":"124","DOI":"10.5498\/wjp.v11.i4.124","article-title":"Chronic serotonin syndrome: a retrospective study","volume":"11","author":"Prakash","year":"2021","journal-title":"World J Psychiatr"},{"key":"2026062707165968000_ref14","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3390\/medicines8060024","article-title":"Recognition and management of antipsychotic-induced parkinsonism in older adults: a narrative review","volume":"8","author":"Wisidagama","year":"2021","journal-title":"Medicines (Basel)"},{"key":"2026062707165968000_ref15","doi-asserted-by":"publisher","first-page":"283","DOI":"10.2147\/SAR.S550775","article-title":"Benzodiazepine use among individuals with opioid use disorder: a narrative review","volume":"16","author":"Liu","year":"2025","journal-title":"Subst Abus Rehabil"}],"container-title":["Oxford Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/omcr\/article-pdf\/2026\/6\/omag107\/68566866\/omag107.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/omcr\/article-pdf\/2026\/6\/omag107\/68566866\/omag107.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T11:17:05Z","timestamp":1782559025000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/omcr\/article\/doi\/10.1093\/omcr\/omag107\/8712680"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":15,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6,8]]}},"URL":"https:\/\/doi.org\/10.1093\/omcr\/omag107","relation":{},"ISSN":["2053-8855"],"issn-type":[{"value":"2053-8855","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,6]]},"published":{"date-parts":[[2026,6]]},"article-number":"omag107"}}